"The large scale Hepatitis C Market report encompasses thorough analysis of Hepatitis C Market industry with respect to several factors that range from market drivers, market restraints, market segmentation, opportunities, challenges, and market revenues to competitive analysis. Furthermore, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. It is the top-notch market research report generated by skilful and experienced team players who support in accomplishing an absolute growth and success in the business. As per Hepatitis C Market business report, the market is expected to grow at a substantial Compound Annual Growth Rate (CAGR) during the forecast period 2023-2030.
Hepatitis C Market document enlists the leading competitors and provides the insights about the strategic industry analysis of the key factors influencing the Hepatitis C Market industry. All the numerical data included in the report is backed up by excellent tools such as SWOT analysis, Porter's Five Forces Analysis and others. This industry report gives accurate information about market trends, industrial changes, and consumer behaviour etc. Businesses can surely anticipate the reduced risk and failure with this market research report. The leading Hepatitis C Market report can be relied upon for sure when thinking about key business decisions.
Data Bridge Market Research analyses that the hepatitis C market was valued at USD 48.51 billion in 2021 and is expected to reach USD 134.54 billion by 2029, registering a CAGR of 13.60% during the forecast period of 2022 to 2029.
Explore Further Details about This Research Hepatitis C Market Report https://www.databridgemarketresearch.com/reports/global-hepatitis-c-market
Report Scope and Market Segmentation
REPORT METRIC | DETAILS |
Forecast Period | 2022 to 2029 |
Base Year | 2021 |
Historic Years | 2020 (Customizable to 2019 - 2014) |
Quantitative Units | Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered | Type (Acute Hepatitis C, Chronic Hepatitis C, Other), Treatment (Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Others), Diagnosis (Liver Biopsy, Blood Tests, Imaging Tests, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) |
Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered | Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Cadila Pharmaceuticals (India), Eli Lilly and Company (U.S.), LEO Pharma A/S (Denmark), Cipla Inc. (U.S.), Aurobindo Pharma (India), Lupin (India), Sumitomo Corporation (Japan) |
Market Opportunities |
|
Market Definition
The hepatitis C virus causes hepatitis C, a viral infection that mostly affects the liver. Cirrhosis is frequently the result, and it can lead to consequences including liver failure, malignancy, and esophageal and gastric varices. There are usually no signs at the beginning of an infection. Antiviral drugs are a type of medicine that is used to treat viral diseases such as HIV, herpes, hepatitis, and influenza. Vaccines are the most common form of administration for these medications. Furthermore, the majority of these medications are used to treat specific viral infections, but a select handful (broad-spectrum antiviral treatments) are effective against different virus forms. Antiviral medications used to treat viral infections of the liver, such as hepatitis, are known as hepatic antiviral agents.
Hepatitis C market Dynamics
Drivers
- Rise in the prevalence of hepatitis
The rising prevalence of hepatitis is a major factor driving the hepatitis C market's growth rate. According to World Health Organization (WHO) data published in July 2021, an estimated 58 million individuals have chronic hepatitis C virus infection, with 1.5 million new infections occurring each year. The hepatitis C virus is a blood-borne pathogen, and the most common way to contract it is by contact with small amounts of blood. This frequently occurs as a result of improper injections and poor health care.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of hepatitis C market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness about the will expand the hepatitis C market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of hepatitis C market. Along with this, rising geriatric population and surge in medical tourism will enhance the market's growth rate.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the hepatitis C market growth. In March 2021, Dicerna Pharmaceuticals and Roche began a Phase II combo trial for the treatment of chronic hepatitis infection with the experimental GalXC RNAi candidate, RG6346. As a result, market research and development activities are crucial to improve market expansion.
- Launch of new products
The launch of new products is estimated to boost the new market opportunities. Mavyret (glecaprevir and pibrentasvir) pills, for instance, were approved by the US Food and Drug Administration in April 2019 to treat six genotypes of hepatitis C virus (HCV) in children aged 12 to 17. Furthermore, in June 2021, Gilead Sciences, Inc. got FDA approval for Epclusa for the treatment of chronic hepatitis C virus (HCV) in children under the age of three, regardless of HCV genotype or severity of liver disease.
Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the hepatitis C market growth during the forecast period.
Key Benefits of the Report:
- This study presents the analytical depiction of the global Hepatitis C Market ndustry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Hepatitis C Market share.
- The current market is quantitatively analyzed from 2022 to 2029 to highlight the Hepatitis C Market growth scenario.
- Porter's five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Hepatitis C Market analysis based on competitive intensity and how the competition will take shape in coming years.
Why choose Data Bridge Market Research?
- Modern technologies, such as artificial intelligence, to provide updated industry growth.
- DBMR team provides clients with the top notch Hepatitis C Market research report.
- Interaction with research scientists and development heads to understand the nature of the Hepatitis C Market more precisely.
- 24/7 availability of services.
- Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective with Forecast period.
DBMR team uses very fair means to gather information that is scrutinized at every stage while structuring an influential Hepatitis C Market size
Browse Related Reports:
root beer market Size, Analysis and Forecast
Bilateral cystoid macular edema Market Size, Share, Trends & Forecast
Temperature Controlled Packaging Solutions for Pharmaceuticals Market Size And Share Analysis Report,
Soap Dispenser Market by Size, Share, Forecast, & Trends
Intrusion Detection And Prevention Systems (IDPS) Market Size Report- Industry Growth Analysis
Antifouling Yacht Coatings Market Size, Industry Share Forecast
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
"
